- Report
- August 2022
- 108 Pages
Saudi Arabia
From €2955EUR$3,350USD£2,562GBP
- Report
- February 2025
- 150 Pages
Global
From €4278EUR$4,850USD£3,709GBP
- Report
- July 2024
- 302 Pages
Global
From €3175EUR$3,600USD£2,753GBP
- Report
- July 2024
- 136 Pages
Europe
From €1323EUR$1,500USD£1,147GBP
- Report
- July 2024
- 136 Pages
Asia Pacific
From €1323EUR$1,500USD£1,147GBP
- Report
- July 2024
- 120 Pages
North America
From €1323EUR$1,500USD£1,147GBP
- Report
- July 2024
- 136 Pages
Middle East, Africa
From €1323EUR$1,500USD£1,147GBP
- Report
- July 2023
- 82 Pages
Global
From €3500EUR$4,251USD£3,141GBP
The Feline Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and distribution of vaccines for cats. Vaccines are used to protect cats from a variety of diseases, including feline leukemia, rabies, and feline infectious peritonitis. Vaccines are typically administered by veterinarians, and may be given as a single dose or as a series of doses. Vaccines are also available in a variety of forms, including injectable, oral, and intranasal.
The Feline Vaccine market is highly competitive, with a number of companies offering a wide range of products. Companies in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Ceva Animal Health. These companies offer a variety of vaccines, including those for feline leukemia, rabies, and feline infectious peritonitis. Show Less Read more